pentoxifylline has been researched along with Mesenteric Vascular Occlusion in 7 studies
Mesenteric Vascular Occlusion: Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study evaluated the role of pentoxifylline (PTX) and n-acetylcysteine (NAC) in the reduction of ischemia, reperfusion shock and associated intestinal injury." | 3.74 | Effects of pentoxifylline and n-acetylcysteine on injuries caused by ischemia and reperfusion of splanchnic organs in rats. ( Cerqueira, NF; Hussni, CA; Padovani, CR; Sequeira, JL; Yoshida, WB, 2008) |
| "Pentoxifylline had a significant protective effect on severely ischemic bowel when administered during reperfusion at a dosage of 10 mg/kg." | 1.39 | Pentoxifylline protects the small intestine after severe ischemia and reperfusion. ( Cejalvo Lapeña, D; Lloris Carsi, JM; Toledo Pereyra, LH; Toledo, AH; Zaragoza Fernandez, C, 2013) |
| "Pretreatment with pentoxifylline markedly downregulated TNF-α at both the mRNA and protein levels, whereas infliximab pretreatment did not affect the expression of TNF-α induced by I/R." | 1.39 | Tumor necrosis factor-α mediates JNK activation response to intestinal ischemia-reperfusion injury. ( Liu, HL; Tan, SW; Tao, J; Wu, B; Yang, Q; Zhan, YS; Zheng, FP, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lloris Carsi, JM | 1 |
| Cejalvo Lapeña, D | 1 |
| Toledo, AH | 1 |
| Zaragoza Fernandez, C | 1 |
| Toledo Pereyra, LH | 1 |
| Yang, Q | 1 |
| Zheng, FP | 1 |
| Zhan, YS | 1 |
| Tao, J | 1 |
| Tan, SW | 1 |
| Liu, HL | 1 |
| Wu, B | 1 |
| Cerqueira, NF | 1 |
| Hussni, CA | 1 |
| Yoshida, WB | 1 |
| Sequeira, JL | 1 |
| Padovani, CR | 1 |
| Tireli, GA | 1 |
| Salman, T | 1 |
| Ozbey, H | 1 |
| Abbasoglu, L | 1 |
| Toker, G | 1 |
| Celik, A | 1 |
| Seiffge, D | 1 |
| Weithmann, KU | 1 |
| Mavrelis, PG | 1 |
| Doumanian, H | 1 |
| Weichert, W | 1 |
| Breddin, HK | 1 |
7 other studies available for pentoxifylline and Mesenteric Vascular Occlusion
| Article | Year |
|---|---|
Pentoxifylline protects the small intestine after severe ischemia and reperfusion.
Topics: Animals; Biomarkers; Blood Flow Velocity; Cytoprotection; Disease Models, Animal; Inflammation Media | 2013 |
Tumor necrosis factor-α mediates JNK activation response to intestinal ischemia-reperfusion injury.
Topics: Animals; Antibodies, Monoclonal; Apoptosis; Caspase 3; Caspase 9; Disease Models, Animal; Enzyme Act | 2013 |
Effects of pentoxifylline and n-acetylcysteine on injuries caused by ischemia and reperfusion of splanchnic organs in rats.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Free Radical Scavengers; Hemodynamics; Intestinal M | 2008 |
The effect of pentoxifylline on intestinal anastomotic healing after ischemia.
Topics: Anastomosis, Surgical; Animals; Hematologic Agents; Hydroxyproline; Intestine, Small; Male; Mesenter | 2003 |
Update on the pharmacology of pentoxifylline and its combination with low-dose acetylsalicylic acid (HWA 5112).
Topics: Animals; Aspirin; Blood Flow Velocity; Blood Viscosity; Dose-Response Relationship, Drug; Drug Thera | 1989 |
Pentoxifylline for mesenteric ischemia.
Topics: Humans; Ischemia; Mesenteric Arteries; Mesenteric Vascular Occlusion; Pentoxifylline; Theobromine | 1987 |
Antithrombotic effects of acetylsalicylic acid (ASA) and pentoxifylline in laser-induced thrombosis in rat mesenteric vessels.
Topics: Animals; Aspirin; Dose-Response Relationship, Drug; In Vitro Techniques; Laser Therapy; Male; Mesent | 1985 |